Global Vitamin K Antagonists (VKA) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vitamin K Antagonists (VKA) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vitamin K Antagonists (VKA) by Country/Region, 2017, 2022 & 2028

2.2 Vitamin K Antagonists (VKA) Segment by Type

2.2.1 Oral Vitamin K Antagonists

2.2.2 Injection Vitamin K Antagonists

2.3 Vitamin K Antagonists (VKA) Sales by Type

2.3.1 Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

2.3.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022)

2.4 Vitamin K Antagonists (VKA) Segment by Application

2.4.1 VTE

2.4.2 ACS/MI

2.4.3 AF

2.4.4 Others

2.5 Vitamin K Antagonists (VKA) Sales by Application

2.5.1 Global Vitamin K Antagonists (VKA) Sale Market Share by Application (2017-2022)

2.5.2 Global Vitamin K Antagonists (VKA) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022)

3 Global Vitamin K Antagonists (VKA) by Company

3.1 Global Vitamin K Antagonists (VKA) Breakdown Data by Company

3.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Company (2020-2022)

3.1.2 Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)

3.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Company (2020-2022)

3.2.1 Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022)

3.2.2 Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)

3.3 Global Vitamin K Antagonists (VKA) Sale Price by Company

3.4 Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vitamin K Antagonists (VKA) Product Location Distribution

3.4.2 Players Vitamin K Antagonists (VKA) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vitamin K Antagonists (VKA) by Geographic Region

4.1 World Historic Vitamin K Antagonists (VKA) Market Size by Geographic Region (2017-2022)

4.1.1 Global Vitamin K Antagonists (VKA) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Geographic Region

4.2 World Historic Vitamin K Antagonists (VKA) Market Size by Country/Region (2017-2022)

4.2.1 Global Vitamin K Antagonists (VKA) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vitamin K Antagonists (VKA) Annual Revenue by Country/Region

4.3 Americas Vitamin K Antagonists (VKA) Sales Growth

4.4 APAC Vitamin K Antagonists (VKA) Sales Growth

4.5 Europe Vitamin K Antagonists (VKA) Sales Growth

4.6 Middle East & Africa Vitamin K Antagonists (VKA) Sales Growth

5 Americas

5.1 Americas Vitamin K Antagonists (VKA) Sales by Country

5.1.1 Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022)

5.1.2 Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)

5.2 Americas Vitamin K Antagonists (VKA) Sales by Type

5.3 Americas Vitamin K Antagonists (VKA) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vitamin K Antagonists (VKA) Sales by Region

6.1.1 APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022)

6.1.2 APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022)

6.2 APAC Vitamin K Antagonists (VKA) Sales by Type

6.3 APAC Vitamin K Antagonists (VKA) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vitamin K Antagonists (VKA) by Country

7.1.1 Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022)

7.1.2 Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)

7.2 Europe Vitamin K Antagonists (VKA) Sales by Type

7.3 Europe Vitamin K Antagonists (VKA) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vitamin K Antagonists (VKA) by Country

8.1.1 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022)

8.2 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type

8.3 Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA)

10.3 Manufacturing Process Analysis of Vitamin K Antagonists (VKA)

10.4 Industry Chain Structure of Vitamin K Antagonists (VKA)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vitamin K Antagonists (VKA) Distributors

11.3 Vitamin K Antagonists (VKA) Customer

12 World Forecast Review for Vitamin K Antagonists (VKA) by Geographic Region

12.1 Global Vitamin K Antagonists (VKA) Market Size Forecast by Region

12.1.1 Global Vitamin K Antagonists (VKA) Forecast by Region (2023-2028)

12.1.2 Global Vitamin K Antagonists (VKA) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vitamin K Antagonists (VKA) Forecast by Type

12.7 Global Vitamin K Antagonists (VKA) Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Vitamin K Antagonists (VKA) Product Offered

13.1.3 Sanofi Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 Bristol-Myers Squibb

13.2.1 Bristol-Myers Squibb Company Information

13.2.2 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered

13.2.3 Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Main Business Overview

13.2.5 Bristol-Myers Squibb Latest Developments

13.3 Bayer

13.3.1 Bayer Company Information

13.3.2 Bayer Vitamin K Antagonists (VKA) Product Offered

13.3.3 Bayer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer Main Business Overview

13.3.5 Bayer Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered

13.4.3 Johnson & Johnson Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Genentech (Roche)

13.5.1 Genentech (Roche) Company Information

13.5.2 Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered

13.5.3 Genentech (Roche) Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Genentech (Roche) Main Business Overview

13.5.5 Genentech (Roche) Latest Developments

13.6 Boehringer Ingelheim

13.6.1 Boehringer Ingelheim Company Information

13.6.2 Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered

13.6.3 Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Boehringer Ingelheim Main Business Overview

13.6.5 Boehringer Ingelheim Latest Developments

13.7 Lilly

13.7.1 Lilly Company Information

13.7.2 Lilly Vitamin K Antagonists (VKA) Product Offered

13.7.3 Lilly Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Lilly Main Business Overview

13.7.5 Lilly Latest Developments

13.8 Daiichi Sankyo

13.8.1 Daiichi Sankyo Company Information

13.8.2 Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered

13.8.3 Daiichi Sankyo Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Daiichi Sankyo Main Business Overview

13.8.5 Daiichi Sankyo Latest Developments

13.9 Otsuka

13.9.1 Otsuka Company Information

13.9.2 Otsuka Vitamin K Antagonists (VKA) Product Offered

13.9.3 Otsuka Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Otsuka Main Business Overview

13.9.5 Otsuka Latest Developments

13.10 AstraZeneca

13.10.1 AstraZeneca Company Information

13.10.2 AstraZeneca Vitamin K Antagonists (VKA) Product Offered

13.10.3 AstraZeneca Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AstraZeneca Main Business Overview

13.10.5 AstraZeneca Latest Developments

13.11 Pfizer

13.11.1 Pfizer Company Information

13.11.2 Pfizer Vitamin K Antagonists (VKA) Product Offered

13.11.3 Pfizer Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Pfizer Main Business Overview

13.11.5 Pfizer Latest Developments

13.12 Aspen

13.12.1 Aspen Company Information

13.12.2 Aspen Vitamin K Antagonists (VKA) Product Offered

13.12.3 Aspen Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Aspen Main Business Overview

13.12.5 Aspen Latest Developments

13.13 The Medicines Company

13.13.1 The Medicines Company Company Information

13.13.2 The Medicines Company Vitamin K Antagonists (VKA) Product Offered

13.13.3 The Medicines Company Vitamin K Antagonists (VKA) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 The Medicines Company Main Business Overview

13.13.5 The Medicines Company Latest Developments

14 Research Findings and Conclusion

Table 1. Vitamin K Antagonists (VKA) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vitamin K Antagonists (VKA) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oral Vitamin K Antagonists

Table 4. Major Players of Injection Vitamin K Antagonists

Table 5. Global Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)

Table 6. Global Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

Table 7. Global Vitamin K Antagonists (VKA) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)

Table 9. Global Vitamin K Antagonists (VKA) Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)

Table 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Table 12. Global Vitamin K Antagonists (VKA) Revenue by Application (2017-2022)

Table 13. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application (2017-2022)

Table 14. Global Vitamin K Antagonists (VKA) Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Vitamin K Antagonists (VKA) Sales by Company (2020-2022) & (K MT)

Table 16. Global Vitamin K Antagonists (VKA) Sales Market Share by Company (2020-2022)

Table 17. Global Vitamin K Antagonists (VKA) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company (2020-2022)

Table 19. Global Vitamin K Antagonists (VKA) Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Vitamin K Antagonists (VKA) Producing Area Distribution and Sales Area

Table 21. Players Vitamin K Antagonists (VKA) Products Offered

Table 22. Vitamin K Antagonists (VKA) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vitamin K Antagonists (VKA) Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Vitamin K Antagonists (VKA) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vitamin K Antagonists (VKA) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vitamin K Antagonists (VKA) Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Vitamin K Antagonists (VKA) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vitamin K Antagonists (VKA) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)

Table 34. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)

Table 35. Americas Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)

Table 37. Americas Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)

Table 38. Americas Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

Table 39. Americas Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)

Table 40. Americas Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Table 41. APAC Vitamin K Antagonists (VKA) Sales by Region (2017-2022) & (K MT)

Table 42. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)

Table 43. APAC Vitamin K Antagonists (VKA) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Region (2017-2022)

Table 45. APAC Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)

Table 46. APAC Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

Table 47. APAC Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)

Table 48. APAC Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Table 49. Europe Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)

Table 50. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)

Table 51. Europe Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)

Table 53. Europe Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)

Table 54. Europe Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

Table 55. Europe Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)

Table 56. Europe Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vitamin K Antagonists (VKA) Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vitamin K Antagonists (VKA)

Table 66. Key Market Challenges & Risks of Vitamin K Antagonists (VKA)

Table 67. Key Industry Trends of Vitamin K Antagonists (VKA)

Table 68. Vitamin K Antagonists (VKA) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vitamin K Antagonists (VKA) Distributors List

Table 71. Vitamin K Antagonists (VKA) Customer List

Table 72. Global Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Vitamin K Antagonists (VKA) Sales Market Forecast by Region

Table 74. Global Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vitamin K Antagonists (VKA) Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Vitamin K Antagonists (VKA) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vitamin K Antagonists (VKA) Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vitamin K Antagonists (VKA) Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vitamin K Antagonists (VKA) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vitamin K Antagonists (VKA) Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Vitamin K Antagonists (VKA) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vitamin K Antagonists (VKA) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vitamin K Antagonists (VKA) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Vitamin K Antagonists (VKA) Product Offered

Table 94. Sanofi Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. Bristol-Myers Squibb Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 98. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Product Offered

Table 99. Bristol-Myers Squibb Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Bristol-Myers Squibb Main Business

Table 101. Bristol-Myers Squibb Latest Developments

Table 102. Bayer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 103. Bayer Vitamin K Antagonists (VKA) Product Offered

Table 104. Bayer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Bayer Main Business

Table 106. Bayer Latest Developments

Table 107. Johnson & Johnson Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 108. Johnson & Johnson Vitamin K Antagonists (VKA) Product Offered

Table 109. Johnson & Johnson Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. Johnson & Johnson Main Business

Table 111. Johnson & Johnson Latest Developments

Table 112. Genentech (Roche) Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 113. Genentech (Roche) Vitamin K Antagonists (VKA) Product Offered

Table 114. Genentech (Roche) Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Genentech (Roche) Main Business

Table 116. Genentech (Roche) Latest Developments

Table 117. Boehringer Ingelheim Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 118. Boehringer Ingelheim Vitamin K Antagonists (VKA) Product Offered

Table 119. Boehringer Ingelheim Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Boehringer Ingelheim Main Business

Table 121. Boehringer Ingelheim Latest Developments

Table 122. Lilly Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 123. Lilly Vitamin K Antagonists (VKA) Product Offered

Table 124. Lilly Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Lilly Main Business

Table 126. Lilly Latest Developments

Table 127. Daiichi Sankyo Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 128. Daiichi Sankyo Vitamin K Antagonists (VKA) Product Offered

Table 129. Daiichi Sankyo Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Daiichi Sankyo Main Business

Table 131. Daiichi Sankyo Latest Developments

Table 132. Otsuka Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 133. Otsuka Vitamin K Antagonists (VKA) Product Offered

Table 134. Otsuka Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Otsuka Main Business

Table 136. Otsuka Latest Developments

Table 137. AstraZeneca Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 138. AstraZeneca Vitamin K Antagonists (VKA) Product Offered

Table 139. AstraZeneca Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. AstraZeneca Main Business

Table 141. AstraZeneca Latest Developments

Table 142. Pfizer Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 143. Pfizer Vitamin K Antagonists (VKA) Product Offered

Table 144. Pfizer Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 145. Pfizer Main Business

Table 146. Pfizer Latest Developments

Table 147. Aspen Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 148. Aspen Vitamin K Antagonists (VKA) Product Offered

Table 149. Aspen Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 150. Aspen Main Business

Table 151. Aspen Latest Developments

Table 152. The Medicines Company Basic Information, Vitamin K Antagonists (VKA) Manufacturing Base, Sales Area and Its Competitors

Table 153. The Medicines Company Vitamin K Antagonists (VKA) Product Offered

Table 154. The Medicines Company Vitamin K Antagonists (VKA) Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 155. The Medicines Company Main Business

Table 156. The Medicines Company Latest Developments

List of Figures

Figure 1. Picture of Vitamin K Antagonists (VKA)

Figure 2. Vitamin K Antagonists (VKA) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vitamin K Antagonists (VKA) Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Vitamin K Antagonists (VKA) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vitamin K Antagonists (VKA) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oral Vitamin K Antagonists

Figure 10. Product Picture of Injection Vitamin K Antagonists

Figure 11. Global Vitamin K Antagonists (VKA) Sales Market Share by Type in 2021

Figure 12. Global Vitamin K Antagonists (VKA) Revenue Market Share by Type (2017-2022)

Figure 13. Vitamin K Antagonists (VKA) Consumed in VTE

Figure 14. Global Vitamin K Antagonists (VKA) Market: VTE (2017-2022) & (K MT)

Figure 15. Vitamin K Antagonists (VKA) Consumed in ACS/MI

Figure 16. Global Vitamin K Antagonists (VKA) Market: ACS/MI (2017-2022) & (K MT)

Figure 17. Vitamin K Antagonists (VKA) Consumed in AF

Figure 18. Global Vitamin K Antagonists (VKA) Market: AF (2017-2022) & (K MT)

Figure 19. Vitamin K Antagonists (VKA) Consumed in Others

Figure 20. Global Vitamin K Antagonists (VKA) Market: Others (2017-2022) & (K MT)

Figure 21. Global Vitamin K Antagonists (VKA) Sales Market Share by Application (2017-2022)

Figure 22. Global Vitamin K Antagonists (VKA) Revenue Market Share by Application in 2021

Figure 23. Vitamin K Antagonists (VKA) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Vitamin K Antagonists (VKA) Revenue Market Share by Company in 2021

Figure 25. Global Vitamin K Antagonists (VKA) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Vitamin K Antagonists (VKA) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Vitamin K Antagonists (VKA) Sales Market Share by Region (2017-2022)

Figure 28. Global Vitamin K Antagonists (VKA) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)

Figure 30. Americas Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)

Figure 32. APAC Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)

Figure 34. Europe Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Vitamin K Antagonists (VKA) Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Vitamin K Antagonists (VKA) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021

Figure 38. Americas Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021

Figure 39. United States Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Vitamin K Antagonists (VKA) Sales Market Share by Region in 2021

Figure 44. APAC Vitamin K Antagonists (VKA) Revenue Market Share by Regions in 2021

Figure 45. China Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021

Figure 52. Europe Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021

Figure 53. Germany Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Vitamin K Antagonists (VKA) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Vitamin K Antagonists (VKA) Revenue Market Share by Country in 2021

Figure 60. Egypt Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Vitamin K Antagonists (VKA) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Vitamin K Antagonists (VKA) in 2021

Figure 66. Manufacturing Process Analysis of Vitamin K Antagonists (VKA)

Figure 67. Industry Chain Structure of Vitamin K Antagonists (VKA)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles